Century Therapeutics, Inc
Financing
SEC filings to 2026-10-05 · every row opens its filingShares on issue
180.5M
on 2026-06-30, from 60.3M on 2024-03-31 10-Q ↗
a raise that quarter, at its price
Newest
S-3 of 2025-07-10. Not read yet. S-3 ↗
$150.0M
Cowen and Company, agreement of 2022-07-01. No at-the-market sales statement read from a 10-Q or 10-K. 424B5 ↗
Warrants
The 10-Q filed 2026-08-12 is not read yet.
Cash
5.5 quarters
$119.7M on 2026-06-30 ÷ $21.7M a quarter of operating cash used, the average of four quarters. 10-Q ↗
| Date | What | Shares | Price | Gross | Filing |
|---|---|---|---|---|---|
| 2026-01-07 | Private placement incl. 25.36M pre-funded | 50,721,408 | $1.15 | not stated | 8-K ↗ |